KBC Group NV Boosts Holdings in Select Medical Holdings Co. (NYSE:SEM)

KBC Group NV boosted its holdings in Select Medical Holdings Co. (NYSE:SEM) by 4.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,050 shares of the health services provider’s stock after acquiring an additional 563 shares during the period. KBC Group NV’s holdings in Select Medical were worth $455,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in SEM. Price T Rowe Associates Inc. MD raised its stake in shares of Select Medical by 0.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,202,219 shares of the health services provider’s stock valued at $518,647,000 after acquiring an additional 90,604 shares during the period. Vanguard Group Inc. raised its position in Select Medical by 5.3% in the first quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock valued at $391,886,000 after purchasing an additional 650,093 shares during the period. Dimensional Fund Advisors LP lifted its stake in Select Medical by 2.2% during the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock worth $157,728,000 after purchasing an additional 95,578 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Select Medical by 6.7% during the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after buying an additional 147,032 shares during the period. Finally, Victory Capital Management Inc. grew its stake in shares of Select Medical by 0.6% in the third quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider’s stock valued at $41,184,000 after buying an additional 7,372 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Stock Up 1.1 %

SEM stock opened at $37.01 on Wednesday. The company’s 50 day moving average price is $34.87 and its 200 day moving average price is $34.88. The firm has a market capitalization of $4.79 billion, a price-to-earnings ratio of 17.29, a PEG ratio of 1.95 and a beta of 1.42. Select Medical Holdings Co. has a fifty-two week low of $22.26 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.46 EPS. On average, equities research analysts anticipate that Select Medical Holdings Co. will post 2.16 EPS for the current fiscal year.

Select Medical Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th will be given a dividend of $0.125 per share. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.50 annualized dividend and a dividend yield of 1.35%. Select Medical’s dividend payout ratio is currently 23.36%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on SEM. Benchmark reissued a “buy” rating and set a $48.00 target price on shares of Select Medical in a research note on Friday, November 1st. Bank of America began coverage on shares of Select Medical in a report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective for the company. Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Finally, StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Select Medical presently has a consensus rating of “Moderate Buy” and a consensus price target of $40.75.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.